Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2881-2884

  Hofstra, Robert M W ^a   Stelwagen, Tineke ^a   Stulp, Rein P ^a   De Jong, Debora ^a   Hulsbeek, Miriam ^a   Kamsteeg, Erik J ^a   Van Den Berg, Anke ^a   Landsvater, Rudy M ^b   Vermey, Albert ^a   Molenaar, Willemina M ^a   Lips, Cornelis J M ^b   Buys, Charles H C M ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE RET; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID MEDULLARY CARCINOMA; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; GENES; GENES, TUMOR SUPPRESSOR; HUMANS; LIGASES; PHEOCHROMOCYTOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 10144242640     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2881     Document Type: Article

References (27)

1. Saad MF, Ordenz NG, Rashid RK, et al. 1984 Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine. 63:319-342.
2. Raue F, Kotzerkez J, Reinwein D, et al. 1993 Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Invest. 71:7-12.
3. Neumann HPH, Berger DP, Sigmund G, et al. 1993 Pheochromocytomas multiple endocrine neoplasia type 2 and von Hippel-Lindau disease. N Engl J Med. 329:1531-1538.
4. Calkins E, Howard JE. 1947 Bilateral familial pheochromocytoma with paroxysmal hypertension: successful surgical removal of tumors in 2 cases with discussion of certain diagnostic and physiological considerations. J Clin Endocrinol Metab. 7:475-492.
5. Kaufman JJ, Franklin S. 1979 Familial pheochromocytoma: a report of 2 cases in a kindred. J Urol. 121:801-804.
6. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993 Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458-460.
7. Donis-Keller H, Dou S, Chi D, et al. 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 7:851-856.
8. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 20:509-513.
9. Hofstra RMW, Landsvater RM, Ceccherini I, et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:375-376.
10. Carlson KM, Dou S, Chi D, et al. 1994 Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA. 91:1579-1583.
11. Eng C, Smith DP, Mulligan LM, et al. 1994 Point mutations within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet. 3:237-241.
12. Eng C, Muligan LM, Smith DP, et al. 1995 Mutation of the RET proto-oncogene in sporadic medullary carcinoma. Genes Chrom Cancer. 12:209-213.
13. Zedenius J, Wallin G, Hamberger B, Nordenskjord M, Weber G, Larsson C. 1994 Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC's. Hum Mol Genet. 3:1259-1262.
14. Blaugrund JE, Johns MM, Eby YJ, et al. 1994 RET proto-oncogene mutations in inherited and sporadic medullary thyroid carcinoma. Hum Mol Genet. 3:1895-1897.
15. Kimura T, Yoshimoto K, Yokogoshi Y, Saito S. 1995 Mutations in the cysteinerich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma. Endocr J. 42:517-525.
16. Lindor NM, Honchel R, Khosla S, Thibodeau SN. 1995 Mutations in the RET proto-oncogene in sporadic pheochromocytomas. J Clin Endocrinol Metab. 80:627-629.
17. Latif F, Tory K, Gnarra J, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317-1320.
18. Neumann HPH, Eng C, Mulligan LM, et al. 1995 Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. JAMA. 11:1149-1151.
19. Leong SS, Horoszewicz JS, Shimaoka K, et al. 1981 A new cell line for study of human medullary thyroid carcinoma. In: Andreoli M, Monaco F, Robbins J, eds. Advances in thyroid neoplasia. Rome: Field Educational Italia; 95-108.
20. Taylor LD, Elder FFB, Knuth A, Gagel RF. 1989 Cytogenetic characterization of two human and three rat medullary thyroid carcinoma cell lines. Henry Ford Hosp Med J. 37:207.
21. Ceccherini I, Hofstra RMW, Yin L, et al. 1994 DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene. Oncogene 9:3025-3029.
22. Crossey PA, Richards FM, Foster K, et al. 1994 Identification of intragenic mutations in von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet. 3:1303-1309.
23. Uitterlinden AG, Vijg J. 1994 Two-dimensional DNA typing: a parallel approach to genome analysis. Chichester: Ellis Horwood.
24. Landsvater RM, Rombouts AGM, te Meerman GJ, et al. 1993 The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN 2A kindred. Am J Hum Genet. 52:335-342.
25. Lips CJM, Landsvater RM, Höppener JWM, et al. 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 331:823-835.
26. Pasini B, Borrello MG, Greco A, et al. 1995 Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genet. 10:35-41.
27. Chen F, Kishida T, Yao M, et al. 1995 Germline mutations in the von Hippel-lindau disease tumor suppressor gen: correlation with phenotype. Hum Mutat. 5:66-75.